Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,884 | 36,958 | 37,513 | 22,249 | 46,506 |
| Marketable Securities | 126,598 | 116,874 | 119,817 | 135,264 | 121,782 |
| Receivables | 4,682 | 4,560 | 4,581 | 5,991 | 5,778 |
| Inventories | 8,914 | 10,393 | 11,159 | 11,960 | 12,229 |
| TOTAL | $171,684 | $172,909 | $175,647 | $178,674 | $190,194 |
| Non-Current Assets | |||||
| PPE Net | 19,707 | 20,967 | 21,720 | 22,805 | 23,513 |
| Investments And Advances | 35,781 | 42,797 | 42,481 | 45,031 | 42,938 |
| Other Non-Current Assets | 12,298 | 11,939 | 11,648 | 11,420 | 11,629 |
| TOTAL | $67,786 | $75,703 | $75,849 | $79,256 | $78,080 |
| Total Assets | $239,470 | $248,612 | $251,496 | $257,930 | $268,274 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,358 | 1,865 | 953 | 1,674 | 743 |
| Accrued Expenses | 8,302 | 8,196 | 7,076 | 6,502 | 11,269 |
| TOTAL | $15,775 | $17,621 | $12,275 | $13,477 | $17,855 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,251 | 6,653 | 3,368 | 4,476 | 5,069 |
| Other Non-Current Liabilities | 17,444 | 17,689 | 17,960 | 18,094 | 18,252 |
| TOTAL | $17,444 | $17,689 | $17,960 | $18,094 | $18,252 |
| Total Liabilities | $33,219 | $35,310 | $30,235 | $31,571 | $36,107 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,028 | 105,483 | 105,089 | 104,544 | 104,129 |
| Common Shares | 1,057 | 1,053 | 1,048 | 1,044 | 1,040 |
| Retained earnings | -216,853 | -206,256 | -194,699 | -185,324 | -175,798 |
| TOTAL | $206,251 | $213,302 | $221,261 | $226,359 | $232,167 |
| Total Liabilities And Equity | $239,470 | $248,612 | $251,496 | $257,930 | $268,274 |